StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$5.49−0.34 (-5.84%)

Close on Nov 19, 2026Market cap $102.63MP/E –Yield –

Trinity Biotech shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Trinity Biotech's shares outstanding was 26M at Jun 30, 2018. For fiscal 2025 it was 372M, up 3.4% from the year before. Over ten years it grew 13.0% a year on average. The highest annual figure on record is 372M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025372M+3.4%
FY2024Dec 31, 2024359M+134.6%
FY2023Dec 31, 2023153M+92.5%
FY2022Dec 31, 202280M+115.0%
FY2021Dec 31, 202137M-2.0%
FY2020Dec 31, 202038M-62.9%
FY2019Dec 31, 2019102M-1.6%
FY2018Dec 31, 2018104M-3.7%
FY2017Dec 31, 2017108M-5.0%
FY2016Dec 31, 2016113M+3.3%
FY2015Dec 31, 2015110M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2018Jun 30, 201826M–
Q2 FY2017Jun 30, 201727M–

More Trinity Biotech figures

See a number that looks wrong?